{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:47:14Z","timestamp":1773028034225,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.drudis.2011.12.013","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T05:06:19Z","timestamp":1324357579000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies"],"prefix":"10.1016","volume":"17","author":[{"given":"Hanif","family":"Esmail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Clifton E.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2011.12.013_bib0005","series-title":"Global Tuberculosis Control 2011","author":"WHO","year":"2011"},{"key":"10.1016\/j.drudis.2011.12.013_bib0010","series-title":"The Global Plan to Stop TB 2011\u20132015","author":"Stop TB Partnership","year":"2010"},{"key":"10.1016\/j.drudis.2011.12.013_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1098\/rsif.2007.1138","article-title":"Eliminating human tuberculosis in the twenty-first century","volume":"5","author":"Dye","year":"2008","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.drudis.2011.12.013_bib0020","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2011.12.013_bib0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.2.1560.1193","article-title":"A further communication on a remedy for tuberculosis","volume":"2","author":"Koch","year":"1890","journal-title":"Br. Med. J."},{"key":"10.1016\/j.drudis.2011.12.013_bib0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.1980.tb18901.x","article-title":"Spread of tuberculosis via recirculated air in a naval vessel: the Byrd study","volume":"353","author":"Houk","year":"1980","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drudis.2011.12.013_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/338342","article-title":"Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection","volume":"185","author":"Lillebaek","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2011.12.013_bib0045","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","article-title":"Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak","volume":"361","author":"Ewer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2011.12.013_bib0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2011.12.013_bib0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/596735","article-title":"Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons","volume":"199","author":"Sarrazin","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.immuni.2008.07.015","article-title":"Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block","volume":"29","author":"Matheu","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2011.12.013_bib0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1165\/rcmb.2005-0060OC","article-title":"Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis","volume":"33","author":"Walrath","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2567.2010.03288.x","article-title":"Generation, persistence and plasticity of CD4 T-cell memories","volume":"130","author":"Lees","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.drudis.2011.12.013_bib0075","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2011.12.013_bib0080","first-page":"347","article-title":"Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence?","volume":"14","author":"Tapaninen","year":"2010","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0085","first-page":"511","article-title":"The bentonite granuloma. Characterization of a model system for infectious and foreign body granulomatous inflammation using soluble mycobacterial, Histoplasma and Schistosoma antigens","volume":"24","author":"Boros","year":"1973","journal-title":"Immunology"},{"key":"10.1016\/j.drudis.2011.12.013_bib0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.immuni.2007.12.010","article-title":"Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas","volume":"28","author":"Egen","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2011.12.013_bib0095","first-page":"1","article-title":"Tubercule bacilli in latent tuberculosis lesions and in lung tissue without tuberculosis lesions","volume":"4","author":"Opie","year":"1927","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.micro.112408.134043","article-title":"Letting sleeping dos lie: does dormancy play a role in tuberculosis?","volume":"64","author":"Chao","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-2958.2003.03474.x","article-title":"Rv3133c\/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis","volume":"48","author":"Park","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0110","doi-asserted-by":"crossref","first-page":"e1502","DOI":"10.1371\/journal.pone.0001502","article-title":"The enduring hypoxic response of Mycobacterium tuberculosis","volume":"3","author":"Rustad","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2011.12.013_bib0115","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/IAI.01515-07","article-title":"Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates","volume":"76","author":"Via","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.drudis.2011.12.013_bib0120","doi-asserted-by":"crossref","first-page":"e1001237","DOI":"10.1371\/journal.ppat.1001237","article-title":"Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines","volume":"6","author":"Gideon","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2011.12.013_bib0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa","volume":"16","author":"Black","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0130","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.micinf.2006.03.018","article-title":"Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis","volume":"8","author":"Leyten","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.drudis.2011.12.013_bib0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2009.02.005","article-title":"Eliminating latent tuberculosis","volume":"17","author":"Young","year":"2009","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target","volume":"185","author":"Lin","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0150","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2011.12.013_bib0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-3083.2010.02496.x","article-title":"T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy","volume":"73","author":"Wergeland","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.2299","article-title":"Dominant TNF-alpha(+) Mycobacterium tuberculosis-specific CD4(+) T cell responses discriminate between latent infection and active disease","volume":"17","author":"Harari","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2011.12.013_bib0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"Goletti","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.drudis.2011.12.013_bib0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2011.08.010","article-title":"Tuberculosis patients are characterized by a low-IFN-gamma\/high-TNF-alpha response to methylated HBHA produced in M. smegmatis","volume":"71","author":"Molicotti","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0175","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","article-title":"Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?","volume":"4","author":"Pai","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.drudis.2011.12.013_bib0180","first-page":"682","article-title":"The effect of antimicrobial therapy on the prognosis of primary tuberculosis in children","volume":"69","author":"Lincoln","year":"1954","journal-title":"Am. Rev. Tuberc."},{"key":"10.1016\/j.drudis.2011.12.013_bib0185","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","volume":"2","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drudis.2011.12.013_bib0190","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0195","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-Month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2011.12.013_bib0200","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1086\/499311","article-title":"Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens","volume":"193","author":"Wilkinson","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0205","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","article-title":"Isoniazid preventive therapy and risk for resistant tuberculosis","volume":"12","author":"Balcells","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drudis.2011.12.013_bib0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"Ford","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2011.12.013_bib0215","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkq374","article-title":"Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis","volume":"65","author":"de Steenwinkel","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2011.12.013_bib0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tube.2010.03.007","article-title":"Early clinical development of anti-tuberculosis drugs: science, statistics and sterilizing activity","volume":"90","author":"Davies","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.drudis.2011.12.013_bib0225","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1128\/AAC.00934-10","article-title":"Bactericidal potencies of new regimens are not predictive of their sterilizing potencies in a murine model of tuberculosis","volume":"54","author":"Andries","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2011.12.013_bib0230","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1164\/rccm.201103-0397OC","article-title":"Short-course chemotherapy with TMC\u2013207 and rifapentine in a murine model of latent tuberculosis infection","volume":"84","author":"Zhang","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drudis.2011.12.013_bib0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2011.12.013_bib0240","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"Lin","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.drudis.2011.12.013_bib0245","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.20030846","article-title":"Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment","volume":"198","author":"Schnappinger","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2011.12.013_bib0250","doi-asserted-by":"crossref","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence","volume":"4","author":"Peyron","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2011.12.013_bib0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7150\/ijbs.7.376","article-title":"Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening","volume":"7","author":"Ji","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.drudis.2011.12.013_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrmicro1065","article-title":"Tuberculosis \u2013 metabolism and respiration in the absence of growth","volume":"3","author":"Boshoff","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0265","doi-asserted-by":"crossref","first-page":"e1002287","DOI":"10.1371\/journal.ppat.1002287","article-title":"Fumarate reductase activity maintains an energized membrane in anaerobic mycobacterium tuberculosis","volume":"7","author":"Watanabe","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2011.12.013_bib0270","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tim.2011.03.008","article-title":"Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier","volume":"19","author":"Rhee","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0275","doi-asserted-by":"crossref","first-page":"e1000767","DOI":"10.1371\/journal.pgen.1000767","article-title":"Comprehensive functional analysis of Mycobacterium tuberculosis toxin\u2013antitoxin systems: implications for pathogenesis, stress responses, and evolution","volume":"5","author":"Ramage","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.drudis.2011.12.013_bib0280","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1208813","article-title":"Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis","volume":"333","author":"Shi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.drudis.2011.12.013_bib0285","doi-asserted-by":"crossref","first-page":"e13356","DOI":"10.1371\/journal.pone.0013356","article-title":"Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses","volume":"5","author":"Tan","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2011.12.013_bib0290","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.tube.2008.01.007","article-title":"Resuscitation-promoting factors are expressed in Mycobacterium tuberculosis-infected human tissue","volume":"88","author":"Davies","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.drudis.2011.12.013_bib0295","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/CVI.00492-10","article-title":"Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals","volume":"18","author":"Commandeur","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1574-695X.2009.00606.x","article-title":"Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling","volume":"58","author":"Kana","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2011.12.013_bib0310","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10069","article-title":"Metabolite-enabled eradication of bacterial persisters by aminoglycosides","volume":"473","author":"Allison","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2011.12.013_bib0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tim.2006.11.008","article-title":"Vaccine strategies against latent tuberculosis infection","volume":"15","author":"Andersen","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.drudis.2011.12.013_bib0320","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2011.12.013_bib0325","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled phase i clinical trial of the therapeutical antituberculous vaccine RUTI","volume":"28","author":"Vilaplana","year":"2010","journal-title":"Vaccine"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644611004405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644611004405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:11:28Z","timestamp":1761221488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644611004405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":65,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1359644611004405"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2011.12.013","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2011.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}